Has Julie Park, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,904 in general payments to Julie Park, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Julie Park, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Julie Park, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Julie Park, MD

Plastic and Reconstructive Surgery · Chicago, ILNPI 1316084593

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.

$6,904in general payments, 2019–2025

Across 82 payments — averaging $84.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sientra, Inc.$2K
AbbVie$1K
Mentor Worldwide LLC$466
Avita Medical Americas, LLC$343
KCI USA, Inc.$325
Davol Inc.$295
plus $3K from 20 others

What the payments were for

Food & beverage$6,904100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sientra, Inc.	18	$1,585
AbbVie(2 entities)	12	$1,262
Mentor Worldwide LLC	9	$466
Avita Medical Americas, LLC	4	$343
KCI USA, Inc.	3	$325
Davol Inc.	3	$295
TELA Bio, Inc.	2	$291
Integra Lifesciences Corporation	4	$255
Motiva USA, LLC	2	$196
Musculoskeletal Transplant Foundation Inc.	2	$180
Axogen	3	$168
Kerecis Limited	1	$157
Zimmer Biomet	2	$146
Vioptix Inc	2	$143
Polynovo North America LLC	1	$130
Aroa Biosurgery Incorporated	1	$126
Solventum Corporation	2	$110
Baxter Healthcare	1	$109
Biocircuit Technologies Inc	1	$106
Johnson & Johnson	2	$100
Tepha Inc	1	$93
Stryker	1	$82
W. L. Gore & Associates, Inc.	1	$76
Medline Industries LP	2	$74
RTI Surgical, Inc	1	$67
Organogenesis Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$1,112
NATRELLE SALINE-FILLED BREAST IMPLANTS$1,031
Kerecis Omega3 SurgiClose$471
OviTex 2S$291
Phasix Mesh$276
RECELL$240
Kerecis Omega3 GraftGuide$157
Kerecis Omega3 Marigen$157
PREVENA$155
VAC VERAFLO$155
CODMAN CERTAS$128
SURGIMEND$128
PRIMATRIX$128
NEURAGEN$128
Motiva Implant Matrix$125
MENTOR MemoryGel Resterilizable Gel Sizer$110
ARTISS$109
VAC VERAFLO CLEANSE CHOICE$109
Cohealyx$106
PERMEADERM$106

How this compares

$6,904 in reported general payments places this provider in the 75th percentile of 126 plastic and reconstructive surgery providers in Illinois.

See all plastic and reconstructive surgery providers in Illinois →

Medicare billing

Part B allowed, 2024

$34,154

Medicare patients

Services billed

130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	12	$132
Gabapentin	13	$60

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Chicago

John KimChicago$7.3M
Julius FewChicago$148K
Gregory DumanianChicago$50K
Stefan SzczerbaChicago$29K
Amir DorafsharChicago$29K
Michael HornChicago$14K
Lindsay JanesChicago$14K
Georgios KokosisChicago$13K
Cristin CoquillardChicago$13K
Brian BraithwaiteChicago$12K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →